A recent study reveals that individuals who stop using blockbuster slimming jabs like semaglutide or tirzepatide can put back on shed pounds much more quickly than those who stop traditional diet and exercise plans.
Published data in a leading medical journal demonstrates that while obese individuals frequently drop a large proportion of their total mass while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month once they quit.
"Users buying such medications must be cognizant of the potential of rapid weight regain when the medication ends," cautioned researcher Dr. Susan Jebb.
This pace of regain means a reversion to starting weight in about one and a half years.
Comparing Therapies
The research, which looked at dozens of studies involving over 9,000 of participants, contrasted the effects of these new drugs with other pills.
The team point out that individuals who shed pounds through lifestyle changes alone typically see a slower creep back—approximately 0.1 kg a month—post-intervention.
Explaining the Fast Rebound
Nutrition scientists suggest the way of the injections accounts for the heightened rebound.
These medications imitate a natural hormone called GLP-1, which moderates appetite.
"Sustained high doses of GLP-1 concentrations several times higher than normal might result in the system to produce less of its own natural GLP-1, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.
"Discontinuation of this medication results in appetite is uncontrolled, making binge eating much more probable."
A Chronic Issue?
Health authorities advise the injections for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.
Professionals say that, considering the likelihood of relapse, the treatment should be considered life-long.
This opinion is reinforced by pharmaceutical companies, who state that the findings "emphasize the chronic character of excess weight," akin to managing diseases like high blood pressure.
User Testimonies
Users who have stopped the medication report a sudden return of hunger.
"I experienced a trigger flipping and I was suddenly ravenous," recalled an individual.
The struggle is compounded if users have not adopted lasting lifestyle or habit modifications during therapy.
Widespread Interest
Survey data indicate that millions of people in the UK have used weight-loss jabs in the last 12 months, with interest remaining high.
- Use is greater among females compared to males.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion obtain the medications through private prescriptions rather than public health services.
Ultimately, clinicians emphasize that while these medications are powerful agents for shedding pounds, they are not a magic solution and long-term success likely depends on integrated behavioural management.